This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Congenital Heart Disease Related Topics 
American Heart News - Heart News
APRIL 17, 2024
Research Highlights: Almost 1 in 5 adults with congenital heart disease living in Israel had or developed an abnormal heart rhythm over five years. Adults with congenital heart disease who developed an irregular heart rhythm in the heart’s upper.
American Heart News - Heart News
FEBRUARY 22, 2024
Statement Highlights: A new American Heart Association scientific statement updates more than a decade of research identifying, managing and preventing neurodevelopmental delays and disorders among people with congenital heart disease.
American College of Cardiology
NOVEMBER 19, 2024
What is the impact of intraoperative His bundle (HB) mapping during complex biventricular congenital heart disease (CHD) repair on postoperative atrioventricular block requiring pacemaker (AVB/PM)?
Heart BMJ
SEPTEMBER 25, 2024
Congenital heart defects are the most common type of birth defect, affecting 1% of live births. The underlying cause of congenital heart disease is frequently unknown.
Frontiers in Cardiovascular Medicine
JUNE 3, 2024
The prevalence of congenital heart disease (CHD) in adult patients has risen with advances in diagnostic and surgical techniques. Patients with CHD commonly experience both supraventricular and ventricular arrhythmias, with each CHD type associated with different arrhythmia patterns.
Frontiers in Cardiovascular Medicine
MAY 30, 2024
Adult congenital heart disease Pregnancy Transition of care Challenges heart failure.
Med Page Today
MARCH 1, 2024
(MedPage Today) -- Among babies with severe congenital heart disease (CHD), neurological abnormalities tended to cluster in those who had been exposed to some placental pathology while still in the womb, a single-center prospective study found.
Medical Xpress - Cardiology
SEPTEMBER 18, 2024
The global prevalence of congenital heart disease is higher among women who live at high altitudes, according to a new study presented at ACC Latin America 2024 in Punta Cana, Dominican Republic.
Science Daily - Heart Disease
FEBRUARY 8, 2024
An advanced human heart organoid system can be used to model embryonic heart development under pregestational diabetes-like conditions, researchers report. The organoids recapitulate hallmarks of pregestational diabetes-induced congenital heart disease found in mice and humans.
American College of Cardiology
SEPTEMBER 18, 2024
The prevalence of congenital heart disease (CHD) is higher among those who live at higher altitudes, and more prevalent among females, according to a new study presented at ACC Latin America 2024.
Medical Xpress - Cardiology
OCTOBER 28, 2024
Single ventricle heart diseases (SVHDs), the most severe type of congenital heart disease, requires immediate treatment after birth. A growing number of fetal therapies make the benefits of early diagnosis even more important.
Heart BMJ
AUGUST 26, 2024
LEARNING OBJECTIVES Review the diagnostic pathway for pulmonary arterial hypertension (PAH) in congenital heart disease (CHD). Understand and interpret right heart catheterisation data in pulmonary hypertension related to CHD. Recognise the typical presentation of PAH in patients with CHD.
HeartRhythm
NOVEMBER 20, 2024
Tetralogy of Fallot (TOF) represents the poster child for monomorphic ventricular tachycardia (MVT) in congenital heart disease. Sustained MVT affects approximately 10% of such patients at 30 years after cardiac repair and is inextricably related to the burden of sudden cardiac death (SCD).(1)
American College of Cardiology
MARCH 19, 2024
Developments in cardiovascular (CV) surgery and related care have led to the improved survival of patients with congenital heart disease (CHD) and more teenagers and adults living with congenital heart disease (ACHD).
Journal of the American Heart Association
JANUARY 9, 2024
Journal of the American Heart Association, Ahead of Print. The increasing prevalence of atrial fibrillation (AF) in adults with congenital heart disease raises significant questions regarding its management. Emerging imaging modalities and ablation techniques might have a role to play.
American College of Cardiology
MARCH 25, 2024
In this panel discussion, host Andrea Price MS, AACC brings together Tricia Keegan, NP, DNP, FACC, Disty Pearson, PA-C, AACC, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. In this episode, the focus is on congenital heart disease.
Heart Sisters
OCTOBER 22, 2023
Many adults born with congenital heart disease have never met anyone else with a similar condition - which is where patient support organizations shine!
American College of Cardiology
FEBRUARY 15, 2024
The following are key points to remember from a guideline comparison on participation in competitive sports by patients with congenital heart disease.
American College of Cardiology
MAY 23, 2024
The following are key points to remember from a science advisory on advancing wearable biosensors for patients with congenital heart disease.
American College of Cardiology
MARCH 11, 2024
The following are key points to remember from an American Heart Association Scientific Statement on neurodevelopmental outcomes for individuals with congenital heart disease, which includes updates in neuroprotection, risk-stratification, evaluation, and management.
Journal of the American Heart Association
SEPTEMBER 12, 2024
Due to improvements in recognition and management of their multisystem disease, the long‐term survival of infants, children, and adolescents with trisomy 21 and congenital heart disease now matches children with congenital heart disease and no genetic condition in many scenarios.
American College of Cardiology
JUNE 4, 2024
addressed the safety, tolerability, and outcomes of patients with adult congenital heart disease (ACHD) treated with sodium-glucose cotransporter 2 inhibitors (SGLT2i). Neijenhuis et al. and Fusco et al.
American College of Cardiology
JUNE 6, 2024
The following are key points to remember from an American Heart Association scientific statement on the evaluation and management of chronic heart failure (HF) in children and adolescents with congenital heart disease (CHD).
American College of Cardiology
JANUARY 19, 2024
What is the prevalence of elevated levels of anxiety and depression in adults with congenital heart disease (ACHD)?
Medical Xpress - Cardiology
MAY 16, 2024
Congenital heart disease (CHD) includes a variety of structural malformations affecting the heart and blood vessels. With growing understanding of the molecular processes involved in heart development, genetic variants have been proven to play a crucial role in the development of CHD.
Medical Xpress - Cardiology
JANUARY 1, 2024
For adults with congenital heart disease (ACHD), those with heart failure (HF) hospitalizations have an increased risk for mortality and morbidity, according to a study published in the Dec. 5 issue of the Journal of the American Heart Association.
American College of Cardiology
FEBRUARY 2, 2024
February marks Congenital Heart Defect Awareness Week, an opportunity to reflect on the remarkable advancements in the care for congenital heart disease (CHD). Historically viewed with a grim outlook, CHD has journeyed from a potentially lethal condition to a chronic disease managed into adulthood.
Medical Xpress - Cardiology
SEPTEMBER 12, 2024
A coordinated, multidisciplinary health care team to address the specific physical, psychological and developmental needs of children with Trisomy 21, or Down syndrome, and congenital heart disease may help children with these conditions lead longer and more productive lives, according to a new scientific statement from the American Heart Association. (..)
Circulation
FEBRUARY 22, 2024
Over the past decade, new research has advanced scientific knowledge of neurodevelopmental trajectories, factors that increase neurodevelopmental risk, and neuroprotective strategies for individuals with congenital heart disease.
Journal of Cardiothoracic Surgery
FEBRUARY 9, 2024
Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur.
Conquering CHD
JANUARY 16, 2024
This was a bold move at the time, when most patients with his congenital heart condition — dextro-transposition of the great arteries, or d-TGA — were advised to avoid exercise and strenuous activity. The post Pushing Boundaries with Adult Congenital Heart Disease: Chris’ Story appeared first on Conquering CHD.
Frontiers in Cardiovascular Medicine
APRIL 7, 2024
Congenital heart disease is a prevalent birth defect, accounting for approximately one-third of major birth defects. In response, we have released a dataset containing 828 DICOM chest x-ray files from children with diagnosed congenital heart disease, alongside corresponding cardiac ultrasound reports.
Open Heart
DECEMBER 14, 2023
Objective To determine the magnitude of any excess risk of mortality and hospitalisation due to COVID-19 infection in patients with congenital heart disease (CHD) in the UK healthcare system.
98 Circulation
NOVEMBER 11, 2024
Background/Introduction:Adults with congenital heart disease have higher rates of anxiety, depression, and suicide, compared to those without congenital heart disease. Circulation, Volume 150, Issue Suppl_1 , Page A4147236-A4147236, November 12, 2024.
Frontiers in Cardiovascular Medicine
JULY 22, 2024
It will also discuss the clinical applications of MRI in diagnosing and monitoring placental insufficiency, as well as its implications for fetal growth restriction (FGR) and congenital heart disease (CHD).
Frontiers in Cardiovascular Medicine
APRIL 23, 2024
Due to the challenges posed by the unique group of fetuses and the dynamic organ of the heart, research into the application of AI in the prenatal diagnosis of congenital heart disease (CHD) is particularly active.
HeartRhythm
JUNE 30, 2024
Atrial arrhythmias are an important source of morbidity in adults with congenital heart disease (CHD) and have been linked to sudden death in certain subgroups. Whereas intra-atrial reentrant tachycardia (IART) is the most common arrhythmia, the prevalence of atrial fibrillation (AF) is increasing.
Frontiers in Cardiovascular Medicine
NOVEMBER 28, 2024
Atrioventricular nodal reentrant tachycardia (AVNRT) is a common supraventricular tachycardia in children and congenital heart disease (CHD) patients. Nowadays, in large enough children, chronic treatment for symptomatic and recurrent AVNRT episodes relies on transcatheter ablation.
DAIC
MARCH 13, 2024
New Jersey-based Atlantic Health System’s Morristown Medical Center and New York-based NYU Langone Health, both nationally recognized cardiovascular programs, have announced that they are expanding their partnership to provide patients improved access to adult congenital heart disease services and the specialist directed care.
Frontiers in Cardiovascular Medicine
OCTOBER 7, 2024
BackgroundAs a minimally invasive approach to treating congenital heart disease (CHD), the application of the right subaxillary small incision (RSSI) has been developing fast in its indication spectrum.
Frontiers in Cardiovascular Medicine
JANUARY 10, 2024
Background While research on congenital heart disease has been extensively conducted worldwide, comprehensive studies from developing countries and the Arab world remain scarce. Aim This study aims to perform a bibliometric review of research on congenital heart disease in the Arab world from 1997 to 2022.
Circulation
MARCH 28, 2024
Wearable biosensors (wearables) enable continual, noninvasive physiologic and behavioral monitoring at home for those with pediatric or congenital heart disease. Challenges related to the use of wearables are common to every clinical setting, but specific topics for consideration in congenital heart disease are highlighted.
HeartRhythm
SEPTEMBER 7, 2024
Cardiac device therapy is frequently required for individuals with adult congenital heart disease (ACHD), whether it be for bradyarrhythmia, ventricular tachyarrhythmia, or cardiac resynchronization therapy (CRT).
Medical Xpress - Cardiology
FEBRUARY 22, 2024
More than a decade of new knowledge about neurodevelopmental risk in people with congenital heart disease has changed the thinking about who is most at risk and the factors that impact neurological development, learning, emotions and behaviors, according to a new American Heart Association statement published in Circulation.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content